Manuscripts
Showing 1596 manuscripts.
Feasibility of Identifying Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease
Citation
A Gupta, S Swindells, S Kim, MD Hughes, L Naini, X Wu, R Dawson, V Mave, J Sanchez, A Mendoza, P Gonzales, N Kumarasamy, K Comins, F Conradie, J Shenje, SN Fontain, A Garcia-Prats, A Asmelash, S Nedsuwan, L Mohapi, UG Lalloo, ACG Ferreira, C Mugah, M Harrington, L Jones, S Cox, B Smith, NS Shah, AC Hesseling, G Churchyard, ATCG 5300/IMPAACT I2003 PHOENIx Feasibility Study Team. Feasibility of Identifying Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease. Clinical Infectious Diseases. 2020 Jan 16; 70(3):425-435. PMID: 30942853; PMCID: PMC7188224.Year
2020
Journal
Clinical Infectious Diseases
Study
IMPAACT 2003/ACTG 5300
Association of Virologic Failure and Nonnucleoside Reverse Transcriptase Inhibitor Resistance Found in Antiretroviral-Naive Children Infected With Human Immunodeficiency Virus and Given Efavirenz-Based Treatment.
Citation
N Higa, A Pelz, D Birch, AI Beck, P Samson, M Bwakura-Dangarembizi, C Bolton-Moore, E Capparelli, E Chadwick, LM Frenkel. Association of Virologic Failure and Nonnucleoside Reverse Transcriptase Inhibitor Resistance Found in Antiretroviral-Naive Children Infected With Human Immunodeficiency Virus and Given Efavirenz-Based Treatment. Journal of the Pediatric Infectious Diseases Society. 2020 Jun 01; 9(2):261-264. PMID: 31194860; PMCID: PMC7192398.Year
2020
Journal
Journal of the Pediatric Infectious Diseases Society
Study
P1070
Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir
Citation
Xiaomei Liu, Jeremiah D Momper, Natella Rakhmanina, John N van den Anker, Dionna Green, Gilbert J Burckart, Brookie M Best, Mark Mirochnick, Edmund V Capparelli, André Dallmann. Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir. Journal of Clinical Pharmacology. 2020 Feb 01; 60(2):240-255. PMID: 31489678; PMCID: PMC7316130.Year
2020
Journal
Journal of Clinical Pharmacology
Study
P1026S
Association between caregiver depression symptoms and child executive functioning. Results from an observational study carried out in four sub-Saharan countries
Citation
I Familiar, M Chernoff, H Ruisenor-Escudero, B Laughton, C Joyce, L Fairlie, V Tichaona, P Kamthunzi, L Barlow-Mosha, B Zimmer, K McCarthy, M Boivin. Association between caregiver depression symptoms and child executive functioning. Results from an observational study carried out in four sub-Saharan countries. AIDS Care. 2020 Apr 01; 32(4):486-494. PMID: 31462095; PMCID: PMC7047586.Year
2020
Journal
AIDS Care
Study
P1104s
Enrollment and transition challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) network's PROMISE trial for resource-limited regions
Citation
Konstantia Angelidou, Mary Glenn Fowler, Pat Flynn, Anne Coletti, Katie McCarthy, Renee Browning, James McIntyre, Sean S Brummel, David E Shapiro, Camlin Tierney, PROMISE study team. Enrollment and transition challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) network's PROMISE trial for resource-limited regions. Clinical Trials. 2020 Aug 01; 17(4):437-447. PMID: 32191142; PMCID: PMC7415523.Year
2020
Journal
Clinical Trials
Study
1077HS, 1077BF, 1077FF
Streptococcus pneumoniae colonization in pneumococcal vaccine-naïve HIV-exposed infected and -uninfected South African children
Citation
M Nunes, S Kim, B Zeldow, A Violari, S Dittmer, H Cassim, T Thomas, N van Niekerk, M Cotton, C Mitchell, P Adrian, S Madhi on behalf of the P1041 team. Streptococcus pneumoniae colonization in pneumococcal vaccine-naïve HIV-exposed infected and -uninfected South African children. Medicine. 2020 Feb 19; 99(9):e19353. PMID: 32118776; PMCID: PMC7478396.Year
2020
Journal
Medicine
Study
P1041
The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial
Citation
Patience Atuhaire, Sean S Brummel, Blandina Theophil Mmbaga, Konstantia Angelidou, Lee Fairlie, Avy Violari, Gerhard Theron, Cornelius Mukuzunga, Sajeeda Mawlana, Mwangelwa Mubiana-Mbewe, Megeshinee Naidoo, Bonus Makanani, Patricia Mandima, Teacler Nematadzira, Nishi Suryavanshi, Tapiwa Mbengeranwa, Amy Lofits, Michael Basar, Katie McCarthy, Judith S Currier, Mary Glenn Fowler, 1077BF/1077FF PROMISE Team. The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial. PLoS One. 2020 Jan 30; 15(1):e0228003. PMID: 31999753; PMCID: PMC6992010.Year
2020
Journal
PLoS One
Study
1077BF, 1077FF
Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children
Citation
E McFarland, R Karron, P Muresan, C Cunningham, J Libous, C Perlowski, B Thumar, D Gnanashanmugam, J Moye, E Schappell, E Barr, V Rexroad, L Fearn, S Spector, M Aziz, M Cielo, C Beneri, A Wiznia, C Luongo, P Collins, U Buchholz, IMPAACT 2011 Study Team. Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children. Journal of Infectious Diseases. 2020 Feb 03; 221(4):534-543. PMID: 31758177; PMCID: PMC6996856.Year
2020
Journal
Journal of Infectious Diseases
Study
IMPAACT 2011
Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial
Citation
Jim Aizire, Kristina Brooks, Mark Mirochnick, Patricia M Flynn, Kevin Butler, Jennifer J Kiser, George K Siberry, Terry Fenton, Mae Cababasay, Mary G Fowler, PROMISE Study Team. Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial. Journal of Acquired Immune Deficiency Syndromes. 2020 Feb 01; 83(2):173-180. PMID: 31929405; PMCID: PMC409985.Year
2020
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
1077BF
Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors
Citation
D Yin, C Ludema, S Cole, C Golin, W Miller, M Warshaw, R McKinney ; on behalf of the PENPACT-1 (PENTA 9 / PACTG 390) Study Team. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. PLoS One. 2020 Nov 23; 15(11):e0242405. PMID: 33226999; PMCID: PMC7682873.Year
2020
Journal
PLoS One